Workflow
Capricor Therapeutics, Inc. (CAPR) Q2 2025 Earnings Conference Call Transcript

Group 1 - Capricor Therapeutics, Inc. held its Q2 2025 earnings conference call on August 11, 2025, with key participants including CFO A.J. Bergmann and CEO Linda Marbán [1][2] - The conference call included forward-looking statements regarding the efficacy, safety, and intended utilization of product candidates, as well as future research and development plans [3][4] - The company discussed anticipated conduct and timing of preclinical and clinical studies, patient enrollment in clinical studies, and plans for regulatory filings and potential developments [3]